BIOMAT Database Logo BIOMAT Database Logo

Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins. 1985

W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy

To quantify more precisely the metabolism of apolipoprotein B (apo B) in human beings, an integrated model was developed for the analysis of the isotope kinetics of apo B in very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), and low density lipoproteins (LDL). The experimental basis for model development was a series of 30 triple-isotope studies in which patients received autologous 131I-VLDL, 125I-IDL, and [3H]glycerol as a precursor of VLDL triglycerides. The currently proposed model contains the following components: (a) a VLDL delipidation cascade that has a variable number of subcompartments, (b) a slowly catabolized pool of VLDL, (c) an IDL compartment consisting of two closely connected subcompartments, one of which is outside the immediate circulation, and (d) a two-compartment subsystem for LDL. Because mass data indicate that not all VLDL were converted to LDL, the model allows for irreversible removal of apo B from VLDL (or IDL) subsystems. It accounts for apparent "direct" input of LDL by postulating an early, rapidly metabolized compartment of VLDL that is converted directly to IDL. The model appears to be consistent with specific activity curves from the current triple-isotope studies and with present concepts of lipoprotein physiology; it also can be used to quantify pathways of lipoprotein apo B transport in normal and abnormal states.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D053419 Lipoproteins, IDL A mixture of very-low-density lipoproteins (VLDL), particularly the triglyceride-poor VLDL, with slow diffuse electrophoretic mobilities in the beta and alpha2 regions which are similar to that of beta-lipoproteins (LDL) or alpha-lipoproteins (HDL). They can be intermediate (remnant) lipoproteins in the de-lipidation process, or remnants of mutant CHYLOMICRONS and VERY-LOW-DENSITY LIPOPROTEINS which cannot be metabolized completely as seen in FAMILIAL DYSBETALIPOPROTEINEMIA. Broad-beta Lipoprotein,Floating beta-Lipoprotein,Intermediate Density Lipoprotein,Intermediate-Density Lipoprotein,alpha2-Very-Low-Density Lipoprotein,alpha2-Very-Low-Density Lipoproteins,beta-VLDL Lipoprotein,beta-Very-Low-Density Lipoprotein,beta-Very-Low-Density Lipoproteins,Broad-beta Lipoproteins,Floating beta-Lipoproteins,Intermediate Density Lipoproteins,Intermediate-Density Lipoproteins,Lipoprotein, IDL,Lipoproteins, Intermediate Density,alpha2-VLDL,alpha2-VLDL Lipoprotein,beta-VLDL,beta-VLDL Lipoproteins,Broad beta Lipoprotein,Broad beta Lipoproteins,Density Lipoprotein, Intermediate,Floating beta Lipoprotein,Floating beta Lipoproteins,IDL Lipoprotein,IDL Lipoproteins,Lipoprotein, Broad-beta,Lipoprotein, Intermediate Density,Lipoprotein, Intermediate-Density,Lipoprotein, alpha2-VLDL,Lipoprotein, alpha2-Very-Low-Density,Lipoprotein, beta-VLDL,Lipoprotein, beta-Very-Low-Density,Lipoproteins, Broad-beta,Lipoproteins, Intermediate-Density,Lipoproteins, alpha2-Very-Low-Density,Lipoproteins, beta-VLDL,Lipoproteins, beta-Very-Low-Density,alpha2 VLDL,alpha2 VLDL Lipoprotein,alpha2 Very Low Density Lipoprotein,alpha2 Very Low Density Lipoproteins,beta VLDL,beta VLDL Lipoprotein,beta VLDL Lipoproteins,beta Very Low Density Lipoprotein,beta Very Low Density Lipoproteins,beta-Lipoprotein, Floating,beta-Lipoproteins, Floating

Related Publications

W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Plasma very low density lipoproteins contain a single molecule of apolipoprotein B.
November 1988, Journal of lipid research,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins.
January 1995, Journal of lipid research,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Metabolism of very low density lipoproteins in hyperlipidaemia: studies of apolipoprotein B kinetics in man.
March 1976, European journal of clinical investigation,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Structural organization of apolipoprotein B-100 of human plasma low density lipoproteins. Comparison to B-48 of chylomicrons and very low density lipoproteins.
December 1986, The Journal of biological chemistry,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes.
March 1985, Journal of lipid research,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Enzyme immunoassay for human apolipoprotein B, the major protein moiety in low-density- and very-low-density lipoproteins.
March 1978, Clinical chemistry,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Apolipoprotein A-II can incorporate into plasma very low density lipoproteins.
September 1981, FEBS letters,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
[Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women].
January 1996, Medicina,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Isolation and alignment of the tryptic peptides of alanine apolipoprotein, an apolipoprotein from human plasma very low density lipoproteins.
August 1974, The Journal of biological chemistry,
W F Beltz, and Y A Kesäniemi, and B V Howard, and S M Grundy
Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E.
July 1975, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
Copied contents to your clipboard!